Loading GLRE…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("GLRE","financials")Full statements spill as a table. For one cell: =jivedata("GLRE","Revenue") or =jivedata("GLRE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
GLRE • CIK 0001385613
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Assumed Premiums Written | $636,810 | $698,335 | $773,261 | $756,744 |
| Ceded Premiums Written | $42,762 | $77,070 | $81,852 | $118,976 |
| Premiums Written, Net | $594,048 | $621,265 | $691,409 | $637,768 |
| Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax | $86,930 | $43,565 | $78,311 | $53,154 |
| (Increase) Decrease in Unearned Premiums, Net | $-10,901 | $-1,311 | $-30,265 | $9,230 |
| Income Tax Expense (Benefit) | $100 | $749 | $3,479 | $2,124 |
| Premiums Earned, Net | $583,147 | $619,954 | $661,144 | $646,998 |
| Net Income (Loss) Attributable to Parent | $86,830 | $42,816 | $74,832 | $51,030 |
| Income (Loss) from Equity Method Investments | $28,696 | $33,605 | $35,711 | $27,622 |
| Foreign Currency Transaction Gain (Loss), before Tax | $11,566 | $-5,606 | $8,465 | $-7,642 |
| Other Operating Income (Expense), Net | $6,306 | $2,119 | $0 | $0 |
| Revenues | $667,082 | $696,026 | $729,777 | $683,485 |
| Policyholder Benefits and Claims Incurred, Net | $360,004 | $427,269 | $411,592 | $391,867 |
| Deferred Policy Acquisition Costs, Amortization Expense | $168,877 | $176,775 | $184,853 | $184,135 |
| Other Underwriting Expense | — | $22,857 | $28,627 | $29,479 |
| Other Expenses | — | $16,377 | $21,607 | $22,639 |
| Interest Expense, Deposits | $2,687 | $3,347 | $421 | $226 |
| Interest Expense, Other | $5,344 | $5,836 | $4,366 | $1,985 |
| Benefits, Losses and Expenses | $580,152 | $652,461 | $651,466 | $630,331 |
| Weighted Average Number of Shares Outstanding, Basic | 34,067,974 | 34,097,572 | 33,816,820 | 33,219,880 |
| Weighted Average Number of Shares Outstanding, Diluted | 34,797,859 | 34,653,453 | 34,502,525 | 33,965,540 |
| Management Fee Expense | $7,954 | $9,808 | — | $9,808 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 729,885 | 555,881 | 685,705 | 745,660 |
| General and Administrative Expense | $43,240 | — | — | $46,931 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | $258,890 | $387,144 | $504,555 | $493,409 |
| Debt Securities, Trading | — | — | $65,609 | $172,865 |
| Cash and Cash Equivalents, at Carrying Value | $51,082 | $64,685 | $111,756 | $76,322 |
| Other Investments | $73,293 | $73,160 | $62,911 | $64,925 |
| Restricted Cash and Cash Equivalents | $604,648 | $584,402 | $531,976 | $526,793 |
| Investments | $332,183 | $460,304 | $633,075 | $731,199 |
| Premiums and Other Receivables, Net | $619,401 | $704,483 | $664,381 | $640,870 |
| Reinsurance Recoverable for Unpaid Claims and Claims Adjustments | $25,687 | $85,790 | $81,392 | $94,790 |
| Deferred Policy Acquisition Cost | $79,956 | $82,249 | $99,954 | $96,703 |
| Prepaid Reinsurance Premiums | $17,261 | $29,545 | $39,223 | $63,107 |
| Other Assets | $5,089 | $4,765 | $8,026 | $8,800 |
| Assets | $1,735,307 | $2,016,223 | $2,169,783 | $2,238,584 |
| Liability for Claims and Claims Adjustment Expense | $661,554 | $860,969 | $967,960 | $983,774 |
| Unearned Premiums | $306,310 | $324,551 | $361,704 | $406,490 |
| Reinsurance Payable | $68,983 | $105,892 | $95,853 | $98,437 |
| Funds Held under Reinsurance Agreements, Liability | $17,289 | $21,878 | $16,105 | $33,100 |
| Other Liabilities | $11,795 | $6,305 | $15,460 | $10,348 |
| Convertible Notes Payable | $73,281 | $60,749 | $4,724 | $4,724 |
| Liabilities | $1,139,212 | $1,380,344 | $1,461,806 | $1,540,902 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $3,534 | $3,483 | $3,390 | $3,288 |
| Additional Paid in Capital | $484,532 | $481,551 | $478,910 | $462,563 |
| Retained Earnings (Accumulated Deficit) | $108,029 | $150,845 | $225,677 | $231,831 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $596,095 | $635,879 | $707,977 | $697,682 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Common Stock, Shares, Issued | 35,336,732 | 34,831,324 | 33,897,709 | 32,881,538 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss) Attributable to Parent | $86,830 | $42,816 | $74,832 | $51,030 |
| Net Cash Provided by (Used in) Operating Activities | $7,507 | $111,504 | $210,212 | $200,057 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $100 | $-345 | $-1,259 | $-1,631 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-50,818 | $-6,643 | $-5,355 | $-55,945 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $655,730 | $649,087 | $643,732 | $611,212 |
| Income (Loss) from Equity Method Investments | $28,696 | $33,605 | $35,711 | $27,622 |
| Proceeds from Equity Method Investment, Distribution, Return of Capital | $78,997 | $34,000 | $14,000 | $49,334 |
| Payments to Acquire Equity Method Investments | $130,994 | $128,649 | $95,700 | $53,856 |
| Share-based Payment Arrangement, Noncash Expense | $6,145 | $4,456 | $7,091 | $7,359 |
| Payments to Acquire Trading Securities Held-for-investment | $7,136 | $1,730 | $65,632 | $184,903 |
| Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | — | — | $69 | $10,929 |
| Gain (Loss) on Extinguishment of Debt | $265 | $0 | $0 | $0 |
| Payments to Acquire Other Investments | — | — | $4,100 | $4,640 |
| Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net | — | $335 | $0 | $26 |
| Proceeds from Sale and Maturity of Other Investments | — | — | $2,634 | $2,629 |
| Payments to Acquire Other Productive Assets | — | $1,072 | $441 | $530 |
| Net Cash Provided by (Used in) Investing Activities | $-53,133 | $-96,562 | $-149,170 | $-180,908 |
| Payments for Repurchase of Common Stock | $0 | $7,488 | $9,825 | $24,025 |
| Repayments of Debt | — | — | $55,313 | $53,438 |
| Proceeds from Lines of Credit | — | — | $0 | $0 |
| Repayments of Convertible Debt | $947 | $13,752 | $0 | $0 |
| Repayments of Senior Debt | $17,198 | $0 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $-5,292 | $-21,240 | $-65,138 | $-73,463 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $5,121 | $5,190 | $4,756 | $2,418 |
| Income Taxes Paid, Net | $-1,022 | $223 | $1,222 | $1,807 |
| Increase (Decrease) in Premiums Receivable | $114,344 | $85,082 | $-40,102 | $-114,426 |
| Increase (Decrease) in Reinsurance Recoverable | $12,873 | $60,103 | $-4,398 | $819 |
| Increase (Decrease) in Deferred Policy Acquisition Costs | $-2,435 | $2,293 | $17,705 | $-2,113 |
| Increase (Decrease) in Prepaid Reinsurance Premiums | $-892 | $12,284 | $9,678 | $26,484 |
| Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve | $106,086 | $199,415 | $106,991 | $38,789 |
| Increase (Decrease) in Unearned Premiums | $-1,510 | $18,241 | $37,153 | $23,066 |
| Increase (Decrease) in Reinsurance Payables | $-36,152 | $36,909 | $-10,039 | $-7,666 |
| Increase (Decrease) in Funds Held under Reinsurance Agreements | $4,618 | $-4,589 | $5,773 | $-10,523 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | — | — | $-7,598 | $-2,166 |
| Increase (Decrease) in Other Operating Liabilities | $5,511 | $-3,358 | — | $-111 |